home / stock / nviv / nviv news


NVIV News and Press, InVivo Therapeutics Holdings Corp. From 04/27/22

Stock Information

Company Name: InVivo Therapeutics Holdings Corp.
Stock Symbol: NVIV
Market: NASDAQ

Menu

NVIV NVIV Quote NVIV Short NVIV News NVIV Articles NVIV Message Board
Get NVIV Alerts

News, Short Squeeze, Breakout and More Instantly...

NVIV - Nutex, Repligen top healthcare gainers; Molecular Partners, Agile lead losers' pack

Gainers: Nutex Health (NUTX) +24%. Repligen (RGEN) +14%. Zentalis Pharmaceuticals (ZNTL) +14%. Alkermes (ALKS) +12%. Clever Leaves (CLVR) +8%. Losers: Molecular Partners (MOLN) -37%. Agile Therapeutics (AGRX) -28%. Immunome (IMNM) -1...

NVIV - InVivo Therapeutics slumps 7% on 1-for-25 reverse stock split

InVivo Therapeutics (NASDAQ:NVIV) announces a 1-for-25 reverse stock split of its common stock and a proportionate reduction in its authorized common stock.  It will be effective at 5.00 pm ET on April 26. Stock drops 7% during after hours For further details see: ...

NVIV - InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcom...

NVIV - 7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the term “technology” often brings to mind the broader digitalization movement, tech actually has the most potential in healthcare. Thanks to groundbreaking innovations, we now know much more about the h...

NVIV - InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcom...

NVIV - InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has enrolled 15 patients with acute spinal cord injury into the INSPIRE 2.0 Study, o...

NVIV - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! The week’s almost done with just one more day of trading so let’s start it with the biggest pre-market stock movers for Friday! Source: ventdusud / Shutterstock.com But let’s not get...

NVIV - 3 Biotech Penny Stocks That You Need to Know About In 2021

Best Biotech Penny Stocks to Watch in July 2021 Biotech penny stocks remain some of the hottest stocks of the year so far. While there are hundreds of penny stocks in the biotech industry to choose from, only a handful have a lot to offer investors of all types. To understand which,...

NVIV - Best Penny Stocks To Watch For July 2021

Are These Penny Stocks On Your Watch List Right Now? Looking for some penny stocks to add to your watch list right now? You’re not alone. The millions of traders that have flooded the stock market today are on the hunt for the next big winning trade, and for a good reason. Si...

NVIV - InVivo Therapeutics soars 15% on FDA acceptance of preclinical module for HDE submission

The FDA has accepted InVivo Therapeutics' ([[NVIV]] +15.2%) preclinical module, one of three individual modules required for the company’s humanitarian device exemption ((HDE)) application.FDA acceptance indicates that the Agency has completed its review and has no outstanding question...

Previous 10 Next 10